The Australia MedTech market is projected to grow from USD 8.0 billion in 2023 to USD 13.5 billion by 2032, with a CAGR of 6.03%. Key growth drivers include the rising acceptance of telehealth, increasing chronic disease prevalence, and advancements in medical technology, such as AI and IoT. The market encompasses various segments, including telehealth, medical wearables, and healthcare analytics, catering to diverse applications and end users across the country.
UBS reports that the race for the U.S. presidency remains extremely close, with increasing volatility and uncertainty expected until a winner is declared. Polls indicate a narrow lead for Harris, with varying results from different news sources, highlighting the unpredictable nature of the election.
23:25 15.10.2024
Ralph Hamers, currently CEO of ING Group, will succeed Sergio Ermotti as CEO of UBS on November 1. After transforming ING into a digital banking leader over six years, Hamers will leave ING on June 30 and join UBS on September 1, following a decision not to extend Ermotti's term. This leadership change at UBS comes shortly after a similar transition at Credit Suisse.
23:23 15.10.2024
UBS has lowered its target for L'Oréal to 415 euros, maintaining a 'Neutral' rating. As the world's leading cosmetics group, L'Oréal's sales are primarily driven by skin care (39.9%), make-up (19.7%), and hair care products (15.4%), with significant contributions from luxury and active cosmetics. Geographically, net sales are distributed across Europe (31.6%), North America (27%), and North Asia (25.9%), among others.
23:17 15.10.2024
Walgreens Boots Alliance projects revenue between $147 billion and $151 billion for fiscal 2025, despite a significant increase in operating losses for its healthcare services segment, which reached $14.2 billion in 2024. The company is exploring strategic options for its VillageMD business, aiming to monetize non-core assets while cutting costs by over $1 billion and reducing net debt by $1.9 billion. Adjusted earnings per share for fiscal 2025 are expected to be between $1.40 and $1.80.
The Australia MedTech market is projected to grow from USD 8.0 billion in 2023 to USD 13.5 billion by 2032, with a CAGR of 6.03%. Key growth drivers include the rising acceptance of telehealth, increasing chronic disease prevalence, and advancements in personalized medicine and medical technologies. The market encompasses various segments, including software, hardware, and services, catering to healthcare providers, payers, and pharmaceutical companies across different regions in Australia.
UBS has reduced its price target for L'Oréal from 440 to 415 euros while maintaining a "Neutral" rating. Analyst Guillaume Delmas anticipates a weak third quarter for the cosmetics group, following disappointing sales figures from luxury goods giant LVMH.
22:30 15.10.2024
Insurers, particularly in North America, are increasingly allocating funds to private credit markets, with 96% planning to boost investments in the next two years. Key motivations include diversification, lower volatility, and the pursuit of new asset classes, while maintaining current risk levels. Partnerships with alternative investment managers are also driving this trend, as insurers seek to capitalize on opportunities in a complex regulatory landscape.
Large U.S. banks, including JPMorgan and Bank of America, surpassed Q3 earnings expectations, driven by strong asset and wealth management performance amid rising stock and bond markets. However, most banks increased provisions for potential credit losses, signaling caution for the economy. While JPMorgan's net interest income rose, Wells Fargo experienced a decline, reflecting the challenges of retaining deposits. Investment banking revenues surged, with Citigroup and Goldman Sachs reporting significant gains.
22:17 15.10.2024
Holders are advised to consult tax advisors regarding U.S. federal income tax laws and potential tax implications of Notes transactions. UBS Securities LLC and its affiliates are involved in the offering, which is subject to FINRA Rule 5121 due to conflicts of interest. The Notes are not available to retail investors in the EEA or the UK, making any related sales potentially unlawful under respective regulations.
22:12 15.10.2024
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings